John Friend

John Friend

Chief Executive Officer at KAZIA THERAPEUTICS LIMITED

54 year

Health Technology

Consumer Services

John Friend active positions

Companies	Position	Start	End
KAZIA THERAPEUTICS LIMITED	Chief Executive Officer	30/04/2023	-
	Director/Board Member	31/07/2023	10/08/2023
	Chairman	10/08/2023	17/01/2024
	Chief Tech/Sci/R&D Officer	14/11/2021	30/04/2023

Career history of John Friend

Former positions of John Friend

Companies	Position	Start	End
CELLECTAR BIOSCIENCES, INC.	Chief Tech/Sci/R&D Officer	30/06/2020	01/11/2021
CELLECTAR BIOSCIENCES, INC.	Chief Tech/Sci/R&D Officer	11/04/2017	26/11/2018
Helsinn Therapeutics (U.S.), Inc. Helsinn Therapeutics (U.S.), Inc. Pharmaceuticals: MajorHealth Technology Helsinn Therapeutics (U.S.), Inc. develops, manufactures and supplies pharmaceutical products for treatment of cancer. The company is headquartered in Iselin. NJ.	Chief Tech/Sci/R&D Officer	28/02/2010	31/03/2017
Druggability Technologies Holdings Ltd. (New Jersey)	Chief Tech/Sci/R&D Officer	-	-

Training of John Friend

Southern Methodist University	Undergraduate Degree
Robert Wood Johnson Medical School	Doctorate Degree

Statistics

International

United States	6
Australia	2

Operational

Chief Tech/Sci/R&D Officer	5
Undergraduate Degree	1
Doctorate Degree	1

Sectoral

Health Technology	4
Consumer Services	3

Positions held

Active

Inactive

Listed companies

Private companies

Linked companies

Listed companies	2
KAZIA THERAPEUTICS LIMITED	Health Technology
CELLECTAR BIOSCIENCES, INC.	Health Technology

Private companies	2
Helsinn Therapeutics (U.S.), Inc. Helsinn Therapeutics (U.S.), Inc. Pharmaceuticals: MajorHealth Technology Helsinn Therapeutics (U.S.), Inc. develops, manufactures and supplies pharmaceutical products for treatment of cancer. The company is headquartered in Iselin. NJ.	Health Technology
Druggability Technologies Holdings Ltd. (New Jersey)

See company connections

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

BENEFIT NOW